Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases

We collected 1500 patients with myeloproliferative neoplasms (MPN) and arterial or venous thrombosis (935/565), pooling three independent cohorts previously reported. Long-term treatment with antiplatelet drugs or vitamin K-antagonists (VKA) was given to 1391 (92.7%) patients; 975 (65%) patients rec...

Descripción completa

Detalles Bibliográficos
Autores principales: De Stefano, Valerio, Rossi, Elena, Carobbio, Alessandra, Ghirardi, Arianna, Betti, Silvia, Finazzi, Guido, Vannucchi, Alessandro M., Barbui, Tiziano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232117/
https://www.ncbi.nlm.nih.gov/pubmed/30420642
http://dx.doi.org/10.1038/s41408-018-0151-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232117/
https://www.ncbi.nlm.nih.gov/pubmed/30420642
http://dx.doi.org/10.1038/s41408-018-0151-y

Ejemplares similares